C4 Therapeutics, Inc. CCCC
$3.64
+0.55%
at last close
Financials (TTM)
- Revenue
- $34.86 million
- Net Income
- $-103,801,000
- Net Margin
- -297.76%
- Return on Equity
- -44.31%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 1.72
- Price / Sales
- 11.54
Over the trailing twelve months, C4 Therapeutics, Inc. generated revenue of $34.86 million and net income of $-103,801,000, a net margin of -297.76%.
At the last closing price of $3.64, CCCC trades at 11.54 times sales, with a market capitalization of $402.46 million.
Key Stats
- Last Close
- $3.64
- Market Cap
- $402.46 million
- 52-Week Range
- $1.44 – $5.17
- Average Volume
- 3.70 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.